Top China ADR Portal

China ADR stock research

ADR REPORT: AstraZeneca gains ground; automakers mixed

E-mail Print PDF


SAN FRANCISCO (MarketWatch) -- U.S.-listed shares of overseas companies rose Thursday, with support from AstraZeneca following the drugmaker plan to cut thousands of jobs and from Royal Dutch Shell after its quarterly profit topped expectations.
The Bank of New York Composite ADR Index is up 0.7% to 169.43.
Stocks on Wall Street were slightly higher Thursday after a lower-than-expected inflation figure, but gains were capped by tech stocks after Comcast Corp.'s earnings fell short of expectations and investors fretted about higher expenses at Google Inc. (GOOG :Quote, Profile, Research) .
Shares of AstraZeneca (AZN : Quote, Profile, Research) climbed 2.2% to $57.16 after the Anglo-Swedish company outlined a plan to cut 3,000 jobs over the next three years to offset a soft drug pipeline. The company also posted a 17% rise in quarterly profit to $1.43 billion, or 93 cents a share, but analysts had expected earnings of 95 cents a share.
Sales at AstraZeneca rose 14% to $7.15 billion, above expectations for revenue of $6.9 billion. See full story.


Meanwhile, China Life(601628.SS: Quote, Profile , Research) (LFC: Quote, Profile , Research) (2628.HK: Quote, Profile , Research)
shares were down 2.4% to $43.10. ABN Amro cut the insurer's rating to sell from hold late Wednesday.
Continued...


If you like us, spread the word to the fellow investors on your favorite Social Bookmarking websites
Reddit! Del.icio.us! Mixx! Free and Open Source Software News Google! Live! Facebook! StumbleUpon! TwitThis Joomla Free PHP